NVIV - InVivo Therapeutics Holdings Corp.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Total Revenue
0
0
0
-
-
Operating Expenses
Research Development
5,602
5,602
4,931
11,083
12,557
Selling General and Administrative
5,895
5,895
7,836
13,510
11,506
Total Operating Expenses
11,497
11,497
12,767
24,593
24,063
Operating Income or Loss
-11,497
-11,497
-12,767
-24,593
-24,063
Interest Expense
-
-
-
74
155
Total Other Income/Expenses Net
-587
-587
-10,862
-2,267
593
Income Before Tax
-11,830
-11,830
-23,423
-26,745
-23,438
Income from Continuing Operations
-11,830
-11,830
-23,423
-26,745
-23,438
Net Income
-11,830
-11,830
-23,423
-26,745
-23,438
Net Income available to common shareholders
-11,830
-11,830
-23,423
-26,745
-23,438
Basic EPS
-
-
-140.70
-607.51
-570.01
Diluted EPS
-
-
-140.70
-607.51
-570.01
Basic Average Shares
-
-
166.334
43.932
41.367
Diluted Average Shares
-
-
166.334
43.932
41.367
EBITDA
-
-11,175
-12,676
-26,276
-22,730